Genetics Generation Advancement Corp. (TPEX: 4160)
Health Care · Biotechnology · TW
NT$38.80
-0.26% today · -23.2% 1Y
Genetics Generation Advancement Corp. (TPEX: 4160) operates in the Biotechnology industry within the Health Care sector. The company is valued at $33.50M and employs 169 people.
Over the last twelve months the share price has lost 23.2%, trading between 36.73 and 55.93.
Tweenvest scores Genetics Generation Advancement Corp. across four factors: quality 76/100, value 51/100, growth 34/100, dividend 54/100. Its strongest factor is quality.
4160 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.50M
- Revenue (TTM)
- $19.31M
- P/E
- 60.77
- EPS
- 0.64
- Dividend yield
- 4.54%
- Beta (5Y)
- 0.33
- 52-week high
- NT$55.93
- 52-week low
- NT$36.73
- Avg volume (3M)
- —
- Shares outstanding
- 28.01M
- Employees
- 169
- Next earnings
- —
About Genetics Generation Advancement Corp.
Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan, specializes in providing advanced genetic testing and bioinformatics solutions. The company serves a diverse global clientele across Taiwan, Asia, Europe, and the Americas. GGAC offers a comprehensive array of genetic screenings tailored for various life stages and health needs. These include pre-conception, prenatal, and newborn testing, in addition to adult health management, cancer predisposition, and pharmacogenetic analyses. The company also collaborates with and provides services to institutional partners. Beyond its core genetic services, Genetics Generation Advancement Corp. extends its expertise to encompass life sciences, materials science, sophisticated laboratory informatics, enterprise quality management systems (EQMS), Manufacturing Execution Systems (MES), and efficient electronic data delivery solutions. Originally founded in 2008 as Genesis Genetics Asia Corp., the company officially rebranded and adopted its current name, Genetics Generation Advancement Corp., in February 2016.
- ISIN
- TW0004160007
- Founded
- 2008
- Listed since
- Jun 20, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Biomark Diagnostics Inc.DB: 20B | $34.02M | €0.28 | -4.70% |
| CervoMed Inc.NasdaqCM: CRVO | $33.87M | $2.24 | -30.43% |
| Cell Source, Inc.OTCPK: CLCS | $33.63M | $0.49 | -10.45% |
| Mabion S.A.WSE: MAB | $33.59M | zł8.07 | +0.88% |
| Vivoryon Therapeutics N.V.ENXTAM: VVY | $32.98M | €0.99 | -5.71% |
| QuantaMatrix Inc.KOSDAQ: A317690 | $32.77M | ₩2,170.00 | -6.26% |
| Kringle Pharma, Inc.TSE: 4884 | $32.60M | ¥614.00 | -4.81% |
| Quince Therapeutics, Inc.NasdaqGS: QNCX | $32.58M | $32.03 | +0.95% |
Figures last refreshed Oct 18, 2026.